Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used to treat diabetes and support weight loss, may also have benefits for mental health, particularly among people with bipolar disorder, according to new research from Griffith University.
Diabetes, obesity, and bipolar disorder frequently occur together and may share some underlying biological mechanisms. According to the latest World Health Organization estimates, about one in 200 people worldwid...

5 days ago
28







English (US) ·